Reports for RANBAXY PHARMACEUTICALS CANADA INC.
Company Name
RANBAXY PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
60 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 60 (100%) | |
Discontinuation Reports |
28 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 28 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
39 (44%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RAN-NABILONE | 1MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50986 |
RAN-NABILONE | 0.25MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50989 |
RAN-NABILONE | 0.5MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50992 |
RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91278 |
RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91281 |
RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-02-02 | 2020-02-02 | 105096 |
RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-03-07 | 2020-03-07 | 108130 |
RAN-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-21 | 2017-07-21 | 16588 |